Deltex Medical Group
Financial ratios & Valuation

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-3.13-2.66-4.41-2.85-3.35-44.31-9.23-8.55-5.96-1.33-12.88-44.31
Price/Sales ratio
1.411.431.650.970.851.673.073.662.760.961.260.85
Price/Book Value ratio
1.864.414.053.951.682.552.664.082.910.522.041.68
Price/Cash Flow ratio
-5.12-5.45-5.77-6.16-3.2111.71-108.38-28.43-11.31-1.4344.05-3.21
Price/Free Cash Flow ratio
-4.24-5.24-5.68-6.12-3.1720.44-30.83-8.85-5.07-1.09-44.5820.44
Price/Earnings Growth ratio
-0.16-0.500.090.110.050.49-0.02-0.64N/A0.030.910.05
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
69.86%62.60%68.37%74.65%71.26%73.30%64.51%65.64%70.38%63.34%75.47%71.26%
Operating Profit Margin
-45.95%-52.03%-37.41%-33.01%-19.03%3.12%-43.36%-51.35%-42.22%-59.23%-4.25%-19.03%
Pretax Profit Margin
-47.56%-56.12%-39.77%-35.79%-27.00%-4.93%-35.27%-45.81%-49.03%-76.85%-11.10%-27.00%
Net Profit Margin
-45.35%-54.02%-37.52%-34.08%-25.50%-3.78%-33.27%-42.80%-46.29%-72.18%-9.82%-25.50%
Effective Tax Rate
-4.65%-3.75%-5.63%-4.75%-5.53%24.28%7.21%6.66%5.91%6.08%11.53%-5.53%
Return on Assets
-30.76%-51.60%-35.07%-34.04%-19.86%-2.47%-14.41%-17.92%-18.60%-21.61%-7.18%-19.86%
Return On Equity
-59.56%-165.78%-91.91%-138.28%-50.07%-5.76%-28.83%-47.70%-48.91%-38.97%-17.73%-50.07%
Return on Capital Employed
-49.51%-160.62%-67.62%-80.11%-24.64%3.23%-26.26%-36.08%-29.62%-21.04%-4.78%-24.64%
Liquidity Ratios
Current Ratio
1.990.891.200.901.251.371.60N/AN/AN/A1.031.37
Quick Ratio
1.640.710.970.680.980.991.030.470.431.120.290.99
Cash ratio
0.820.120.170.060.220.380.540.180.170.750.280.22
Days of Sales Outstanding
135.97109.30134.67111.24103.8691.07112.1773.5167.0536.37N/A91.07
Days of Inventory outstanding
236.94122.68138.56184.95174.29293.99383.87374.40407.70401.44280.51174.29
Operating Cycle
372.91231.98273.23296.19278.16385.07496.05447.92474.76437.82280.51278.16
Days of Payables Outstanding
125.82192.78183.59150.3688.68122.4186.21140.16251.7796.99113.5488.68
Cash Conversion Cycle
247.0839.1989.64145.82189.47262.65409.84307.75222.99340.82-44.38262.65
Debt Ratios
Debt Ratio
0.210.270.260.300.240.190.200.320.320.290.560.24
Debt Equity Ratio
0.410.870.691.250.620.450.410.850.850.531.240.62
Long-term Debt to Capitalization
0.16N/A0.270.400.290.270.260.330.310.330.310.29
Total Debt to Capitalization
0.290.460.400.550.380.310.290.460.460.340.420.38
Interest Coverage Ratio
-33.97-34.36-18.22-13.18-5.900.58-3.32N/AN/AN/A-1.08-5.90
Cash Flow to Debt Ratio
-0.86-0.92-1.01-0.51-0.820.48-0.05-0.16-0.30-0.680.06-0.82
Company Equity Multiplier
1.933.212.624.062.522.3222.662.621.802.202.32
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-0.27-0.26-0.28-0.15-0.260.14-0.02-0.12-0.24-0.670.02-0.26
Free Cash Flow / Operating Cash Flow Ratio
1.201.041.011.001.010.573.513.212.221.30-0.980.57
Cash Flow Coverage Ratio
-0.86-0.92-1.01-0.51-0.820.48-0.05-0.16-0.30-0.680.06-0.82
Short Term Coverage Ratio
-1.67-0.92-2.19-1.14-2.383.23-0.42-0.41-0.64-15.120.16-2.38
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A